21 Nov 2012 07:00

Â
Â
Â
Â
Â
Proposed Placing
Â
Â
London, 21 November, 2012 - Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), announces that the Company is in advanced discussions to raise additional funds from a strategic partner and existing shareholders through the issue of new ordinary shares.
Â
The proposed issue of new ordinary shares is not expected to require shareholder approval.
Â
Further details will be announced in due course.
Â
-Ends-
Â
Silence Therapeutics Ali Mortazavi (+44 7768 694739 /Tim Freeborn (+44 20 7491 6520) Email: a.mortazavi@silence-therapeutics.com t.freeborn@silence-therapeutics.com  | N+1 Singer Shaun Dobson/Jennifer Wyllie +44 20 7496 3000 shaun.dobson@n1singer.com jenny.wyllie@n1singer.com  |
Â
Follow the stocks